The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists. Continue Reading

Thanks to modern science, the closely guarded secrets of one of our nation’s most distinctive emblems, maple syrup, are now being revealed. It has recently been reported that maple syrup contains polyphenols and shows ORAC values which compare to commonly eaten fruits and vegetables such as broccoli. Continue Reading

The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications – Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant. Continue Reading

Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women’s Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.’s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea. Continue Reading

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has launched its Oral Transmucosal Fentanyl Citrate (CII) to distributors serving retail pharmacies across the country. Continue Reading

New survey data released today by the Partnership for a Drug-Free America and MetLife Foundation point to the need for continued efforts to combat substance abuse among teens. While there was no significant increase in the abuse of over-the-counter (OTC) cough medicines containing dextromethorphan, the 21st annual Partnership/MetLife Foundation Attitude Tracking Survey (PATS) found an overall waning in teens’ negative perceptions about many drugs along with increases in abuse rates for alcohol, ecstasy, and marijuana. Continue Reading

Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States. Continue Reading

Omega-3 Awareness Day, the nonprofit is proud to announce its plans for the first-ever international awareness day scheduled on March 3rd, 2010 at the University of California, Irvine. Teams of world-renowned doctors founded by Carol A. Locke, MD are scheduled to speak on the science and health benefits of Omega-3 essential fatty acids from 3:00 p.m. to 6:30 p.m. PST in front of thousands of students at UCI. Continue Reading

AstraZeneca today asked the U.S. Food and Drug Administration (FDA) to adopt guidance that will enable AstraZeneca and others to fully engage in real-time, social media conversations that responsibly provide accurate, balanced information on medicines from a known, identifiable and reliable source. Continue Reading

Research and Markets has announced the addition of the “India Pharmaceutical Regulatory Report 2010 + Appendix” report to their offering. Continue Reading